Anti-hiv agents - Open Access .click

Results 161 to 170 of about 295,334 (238)

Drug-Induced Lupus in an HIV-Positive Patient Treated for Tuberculosis: A Case Report. [PDF]

Clin Med Insights Case Rep
Mahmud O, Jahangir A, Waqas SM, Nasir N.
europepmc +1 more source

Deceptive Sex: Rethinking Consent from the Gender Margins

The Modern Law Review, EarlyView.
This article argues that trans people who choose not to disclose, or who lie about, their gender history prior to sexual intimacy should not be prosecuted for sexual offences, at least not in the absence of a clear and express condition pertaining to cis status or biological sex.
Alex Sharpe
wiley +1 more source

A Case of AIDS Diagnosed in the Intensive Care Unit with Concurrent Influenza Infection and <i>Pneumocystis jirovecii</i> Pneumonia. [PDF]

Case Rep Med
Özdemir Y, Bahar İ, Ece G.
europepmc +1 more source

The 15‐Year Survival Advantage: Immune Resilience as a Salutogenic Force in Healthy Aging

Aging Cell, EarlyView.
Human aging shows puzzling diversity: similar aging rates yet vastly different health outcomes. Our study of ~17,500 people revealed a health‐promoting trait (more common in women) linked to strong immune resilience and high expression of TCF7, a key immune gene. This trait enables individuals to fight infections like COVID‐19 more effectively, respond
Muthu Saravanan Manoharan +176 more
wiley +1 more source

Chronic Inflammation: A Multidisciplinary Analysis of Shared Pathways in Autoimmune, Infectious, and Degenerative Diseases. [PDF]

Cureus
Yacine A +5 more
europepmc +1 more source

Immunosenescence Profile Is Associated With Increased Susceptibility to Severe COVID‐19

Aging Cell, EarlyView.
(A) A previous immunosenescence profile in individuals infected with SARS‐CoV2 creates a permissive environment for progression to severe COVID‐19: higher inflammaging, accumulation of exhausted/senescent T cells, an oligoclonal B‐cell repertoire, and accelerated epigenetic age.
Lucas Haniel A. Ventura +40 more
wiley +1 more source

Impact of HCV elimination on metabolism markers in people living with HIV. [PDF]

Sci Rep
de la Casa AD +11 more
europepmc +1 more source

Opportunities and Challenges of Population Pharmacogenomics

Annals of Human Genetics, EarlyView.
ABSTRACT Pharmacological responses can vary significantly among patients from different ethnogeographic backgrounds. This variability can, at least in part, be attributed to population‐specific genetic patterns in genes involved in drug absorption, distribution, metabolism, and excretion, as well as in genes associated with drug‐induced toxicity ...
Yitian Zhou +3 more
wiley +1 more source

Leishmaniasis in IBD Patients: Challenges of a Rare Opportunistic Disease

United European Gastroenterology Journal, EarlyView.
Candida Abreu, Rafael Rocha
wiley +1 more source

Embedding Pharmacogenetics Into Clinical Practice to Improve Patient Outcomes

Annals of Human Genetics, EarlyView.
ABSTRACT Pharmacogenomics, the use of germline genomic data to guide prescription to improve effective and safer medication, holds promise as a clinical intervention. To date in most health systems, there has been limited uptake of pharmacogenomic testing confined to a few single drug–gene associations.
John Henry McDermott +3 more
wiley +1 more source

humans
hiv-1
reverse transcriptase inhibitors

animals
hiv
drug design

molecular structure
structure-activity relationship
acquired immunodeficiency syndrome